Search Results 411-420 of 17531 for Cytology
Participation eligibility · Patients must have documented histological or cytological evidence of tumor(s) of the prostate. · Patients must be ≥ 45 years of age.
If samples are submitted for central testing, additional tissue, cytology, and/or plasma samples are required. Active or history of autoimmune disease or ...
Known abnormal cervical cytology of clinical significance observed within three years prior to randomization (unless the clinical significance has been resolved) ...
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research samples ...
Confirmed diagnosis of leptomeningeal metastases (LM) with positive cerebrospinal fluid (CSF) cytology for malignancy and meningeal enhancement (type 1A, 1B, ...
Must have histological or cytological confirmed diagnosis of locally advanced or metastatic adenocarcinoma of the pancreas, which has progressed on or after one ...
Contact the study team to discuss study eligibility and potential participation. Show more eligibility criteria. Inclusion Criteria: - Histological/cytological ...
Participation eligibility · Histological or cytological diagnosis of a relevant tumor type as per the study protocol and not candidates for curative surgery or ...
Histological or cytological confirmation of epithelial ovarian, primary peritoneal, or fallopian cancer from any previous time point. Recurrent or relapsed ...
... cytology undergoing hyperthermic intraperitoneal chemotherapy. A Study to Compare Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.